Loading…
DeviceTalks Boston has ended

DeviceTalks is a conversation among leaders. It’s an evening for an exchange of ideas, insight and contacts among the pioneers of the medical technology industry. Formerly known as the Big 100, this event is held annually in Boston, Orange County and the Twin Cities.



On July 15th, you’re invited to join us for a discussion with some of the area’s most innovative and influential leaders, including Brian Concannon, CEO, Haemonetics; Duane DeSisto, CEO, Insulet; Carmichael Roberts, General Partner North Bridge Venbtures and Founder of  480 Biomedical, Arsenal Medical, Diagnostics for All, MC10 and Dr. Charles Carignan.



DeviceTalks also features four panel discussions on hot issues facing medtech companies. The descriptions of which can be found below. When you register you are automatically allowed entry into any of the panels listed.

View analytic
Tuesday, July 15 • 4:00pm - 5:30pm
Hot Topics: M&A Megadeals, IP, Financing, and Products Liability Trends for MedTech Companies

Sign up or log in to save this to your schedule and see who's attending!

Tweet Share
  • M&A trends from the perspective of both acquirer and seller
  • IP protection is key to a successful exit
  • Financing best practices from early stage to exit
  • Products liability litigation - what every medtech company needs to know
Moderators
avatar for David Dykeman

David Dykeman

Shareholder; Co-Chair, Medical Technology, Greenberg Traurig
David Dykeman, who co-chairs the firm's global Life Sciences & Medical Technology group, is a registered patent attorney with nearly 20 years of experience in patent and intellectual property law. David's practice focuses on securing worldwide intellectual property protection... Read More →

Speakers
JC

Jed Cohen

Managing Director, Leerink Partners
Jed Cohen joined Leerink Partners as a Managing Director in 2009 to cover the medical technology sector. Jed has over 20 years of Healthcare Investment Banking experience, including 12 years at Citigroup and three years at UBS prior to joining Leerink. Jed’s transaction experience... Read More →
DM

Dirk M. Kuyper

President & CEO, IlluminOSS Medical
Dirk Kuyper brings over twenty five years of successful experience in the commercialization of medical devices. Prior to joining IlluminOss Mr. Kuyper was President and CEO of Alphatec Spine, Inc. (NASDAQ: ATEC), where he led the company to triple revenue to $200M and expanded... Read More →
DP

David Peck

Shareholder; Co-Chair, Life Sciences & Medical Technology Group, Greenberg Traurig
David C. Peck works with emerging growth companies, established entities and private equity firms in executing their strategic plans. He assists companies beginning with corporate formation, obtaining and structuring both equity and debt financing, mergers and acquisitions, as... Read More →
JS

Jeremy Sohn

Managing Director, MPM Capital
Jeremy Sohn joined MPM Capital's Boston Office in 2013 to help lead the firm's interests in mobile health and big data. Prior to MPM, Jeremy provided strategy and operations consulting for multiple healthcare and technology start-up companies.  From 2007-2011, Jeremy was COO... Read More →
ST

Sara Thompson

Shareholder, Greenberg Traurig
Sara K. Thompson concentrates her practice on products liability litigation, with an emphasis on representing manufacturers of medical devices, pharmaceuticals and other consumer products, in litigation in state and federal courts nationwide. Sara has experience managing individual... Read More →

Tuesday July 15, 2014 4:00pm - 5:30pm
Westin Waterfront Boston
  Workshop

Attendees (0)